How to check a doctor and clinic in France
Where to check a doctor's registration, a clinic's licence and the rules that apply in France. Each line links to its official source; 8 of 8 sections have one.
Doctor register
- France's Agence du Numérique en Santé describes the official Annuaire Santé for health professionals and organizations, including RPPS-registered practitioners. source
- The National Medical Council provides a public physician directory on its French-language site. source
Specialist register
- The Annuaire Santé publishes qualification and specialty data where available. source
Clinic licensing
- The French Digital Health Agency describes the institutional listings in Annuaire Santé. For a facility's health authorization confirm with its regional health agency. source
- France's national Digital Health Agency publishes guidance on registering health structures in the official information system. source
Accreditation
- Check an individual facility in the JCI international accreditation directory using the organization name and country. source
- ISQua EEA awards list can be used to check the external evaluation organization and the scope and dates of its award. source
- Haute Autorité de Santé publishes hospital and clinic certification results in Qualiscope. source
Complaints
- France's health ministry outlines patients' complaint and appeal routes, including complaints to a health facility and other routes appropriate to the issue. source
- France's cross-border healthcare body CLEISS publishes its complaints and litigation guide for treatment in France. source
- The European Commission lists CLEISS as a cross-border healthcare National Contact Point. Within the Directive’s scope, the treatment-country contact point provides information on complaints and legal or administrative remedies under local law. source
Medicines regulator
- EMA identifies France's National Agency for the Safety of Medicines and Health Products (ANSM) as the national medicines authority. source
Cell and gene therapy rules
- Cell and gene therapies that qualify as advanced therapy medicinal products (ATMPs) follow the EU centralised marketing-authorisation route. source
- Non-routinely prepared custom ATMPs may be used for an individual prescription in a hospital in the same member state under a physician’s exclusive professional responsibility. The national competent authority must authorise manufacture. source
- EMA and HMA warn that unregulated cell, tissue and gene treatments can cause serious harm. Their warning identifies unregulated dendritic cell products marketed as cancer treatments and advises checking regulatory status for the intended indication. source
Other rules for medical tourists
- Public guidance describes medically assisted reproduction for different-sex couples, female couples and unmarried women, subject to clinical and age criteria. source